The unadjusted median time to symptom resolution was 10 days in both the intervention and placebo groups.
Montelukast didn’t cut time to COVID symptom relief in clinical trial
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- CDC reports rising levels of Mycoplasma pneumonia and RSV in young kids
- Survey: Only a quarter of US adults concerned about RSV, down from 35% in 2023
- 3 doses of mRNA COVID vaccine show advantage against severe outcomes
- Risk of new type 2 diabetes in kids higher after COVID than other respiratory infections, data suggest